Adalimumab in Elderly Patients with Non-Infectious Uveitis. Safety and Efficacy

被引:8
|
作者
Moll-Udina, Aina [1 ]
Miguel Escuder, Lucia [1 ]
Hernanz, Ines [1 ]
Llorenc, Victor [1 ]
Fonollosa, Alex [2 ]
Cordero Coma, Miguel [3 ]
Sainz de la Maza, Maite [1 ]
Espinosa, Gerard [4 ]
Gonzalez Guijarro, J. Jacobo [5 ]
Lopez Lopez, Fernando [6 ]
Alba-Linero, Carmen [7 ]
Hernandez, Marisa [8 ]
Martinez Costa, Lucia [9 ]
Celdran Vivancos, Diego [5 ]
Giralt, Lena [2 ]
Artaraz, Joseba [2 ]
Soler Bartrina, Pablo [10 ]
Jodar Marquez, Margarita [7 ]
Garcia de Vicuna, Rosario [11 ]
Esquinas, Cristina [12 ]
Adan, Alfredo [1 ]
机构
[1] Univ Barcelona, Hosp Clin, Ophthalmol Clin Inst, Dept Ophthalmol, Barcelona, Spain
[2] Univ Basque Country, Cruces Hosp, BioCruces Hlth Res Inst, Dept Ophthalmol, Leioa, Spain
[3] Univ Leon, Univ Hosp Leon, Dept Ophthalmol, IBIOMED, Leon, Spain
[4] Univ Barcelona, Hosp Clin, Dept Autoimmune Dis, Barcelona, Spain
[5] Univ Hosp La Princesa, Dept Ophthalmol, Madrid, Spain
[6] Santiago Hosp, Dept Ophthalmol, Santiago De Compostela, Spain
[7] Univ Malaga, Reg Univ Hosp Malaga, Dept Ophthalmol, Malaga, Spain
[8] Gen Hosp Valencia, Dept Ophthalmol, Valencia, Spain
[9] Univ Dr Peset Hosp, Dept Ophthalmol, Valencia, Spain
[10] Bierzo Hosp, Dept Ophthalmol, Leon, Spain
[11] Univ Hosp La Princesa, Dept Rheumatol, Madrid, Spain
[12] Autonomous Univ Barcelona, Vall Hebron Res Inst, Barcelona, Spain
关键词
Uveitis; uveitic macular edema; adalimumab; elderly; adverse events; efficacy; safety; ANTITUMOR NECROSIS FACTOR; FACTOR-ALPHA THERAPIES; ANTI-TNF THERAPY; RHEUMATOID-ARTHRITIS; BIOLOGIC AGENTS; STANDARDIZATION; IMMUNOGENICITY; METHOTREXATE; EPIDEMIOLOGY; MANAGEMENT;
D O I
10.1080/09273948.2020.1769139
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To assess the efficacy and safety of adalimumab in elderly patients with noninfectious uveitis (NIU). Methods An observational, retrospective, multicenter study was done. Changes in best-corrected visual acuity (BCVA), inflammatory activity parameters, central retinal thickness (CRT), and the occurrence of adverse events (AE) developed during follow-up were recorded. Results A total of 82 eyes from 41 patients 60 years of age and older with noninfectious uveitis treated with adalimumab were included. A significant improvement in BCVA (71.5 to 75.4 letters,p= .001) and in CRT (311.1 mu m to 265 mu m,p= .001) was observed. Moreover, a significant decrease from baseline in the rate of patients with anterior chamber cell (ACC) >0+ (34.6% to 5.7%,p= <0.001) or vitreous haze>0+ (21.3% to 4.3%,p= .002) was determined. AEs were observed in 11 patients (26.8%). Conclusion Adalimumab can be safe and efficacious for the treatment of NIU in patients 60 years of age and older.
引用
收藏
页码:1591 / 1598
页数:8
相关论文
共 50 条
  • [31] Adalimumab for the Treatment of Non-Infectious Uveitis: A Real Life Experience
    Raad, Fatima
    Luque, Paula
    Ledo, Sofia Garcia
    Lozano, Alicia Alda
    Llorens, Victor
    Espejo, Antonio
    Heras, Henar
    Santana, Lucia
    Trapiella, Luis
    Fanlo, Patricia
    Adan, Alfredo
    Espinosa, Gerard
    Navarrete, Nuria
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2024,
  • [32] Adalimumab for the treatment of refractory active and inactive non-infectious uveitis
    Lee, Jonathan T. L.
    Yates, William B.
    Rogers, Sophie
    Wakefield, Denis
    McCluskey, Peter
    Lim, Lyndell L.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2018, 102 (12) : 1672 - 1678
  • [33] The Efficacy of Adalimumab in Children with Chronic Non-infectious Posterior Uveitis and Panuveitis: A Retrospective Cohort Study
    Tao, Tianyu
    Yang, Shizhao
    He, Daquan
    Peng, Xuening
    Wang, Zhenyu
    Jiang, Qi
    Wang, Tianfu
    Su, Wenru
    [J]. OPHTHALMOLOGY AND THERAPY, 2024, 13 (05) : 1239 - 1253
  • [34] The Efficacy of Adalimumab in Children with Chronic Non-infectious Posterior Uveitis and Panuveitis: A Retrospective Cohort Study
    Tianyu Tao
    Shizhao Yang
    Daquan He
    Xuening Peng
    Zhenyu Wang
    Qi Jiang
    Tianfu Wang
    Wenru Su
    [J]. Ophthalmology and Therapy, 2024, 13 : 1239 - 1253
  • [35] Efficacy and safety of the optimisation of biological therapy in non-infectious uveitis: Systematic review
    Salido Olivares, Marina
    Loza Santamaria, Estibaliz
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 52
  • [36] Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry
    Antonio Vitale
    Francesca Della Casa
    Silvana Guerriero
    Gaafar Ragab
    Angela Mauro
    Valeria Caggiano
    Marco Cattalini
    Emanuela Del Giudice
    Rossella Favale
    Carla Gaggiano
    Irene Bellicini
    Maria Pia Paroli
    Mohamed Tharwat Hegazy
    Jurgen Sota
    Abdurrahman Tufan
    Alberto Balistreri
    Ibrahim Almaghlouth
    Francesco La Torre
    Ewa Więsik-Szewczyk
    Maria Tarsia
    Andrea Hinojosa-Azaola
    Eduardo Martín-Nares
    Bruno Frediani
    Gian Marco Tosi
    Alex Fonollosa
    José Hernández-Rodríguez
    Rana Hussein Amin
    Giuseppe Lopalco
    Donato Rigante
    Luca Cantarini
    Claudia Fabiani
    [J]. Ophthalmology and Therapy, 2023, 12 : 1957 - 1971
  • [37] EFFICACY AND SAFETY OF THE OPTIMISATION OF BIOLOGICAL THERAPY IN NON-INFECTIOUS UVEITIS: SYSTEMATIC REVIEW
    Olivares, M. Salido
    Loza, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1743 - 1743
  • [38] Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry
    Vitale, Antonio
    Della Casa, Francesca
    Guerriero, Silvana
    Ragab, Gaafar
    Mauro, Angela
    Caggiano, Valeria
    Cattalini, Marco
    Del Giudice, Emanuela
    Favale, Rossella
    Gaggiano, Carla
    Bellicini, Irene
    Paroli, Maria Pia
    Hegazy, Mohamed Tharwat
    Sota, Jurgen
    Tufan, Abdurrahman
    Balistreri, Alberto
    Almaghlouth, Ibrahim
    La Torre, Francesco
    Wiesik-Szewczyk, Ewa
    Tarsia, Maria
    Hinojosa-Azaola, Andrea
    Martin-Nares, Eduardo
    Frediani, Bruno
    Tosi, Gian Marco
    Fonollosa, Alex
    Hernandez-Rodriguez, Jose
    Amin, Rana Hussein
    Lopalco, Giuseppe
    Rigante, Donato
    Cantarini, Luca
    Fabiani, Claudia
    [J]. OPHTHALMOLOGY AND THERAPY, 2023, 12 (04) : 1957 - 1971
  • [39] Effect of Adalimumab on Peripheral Blood Mononuclear Cells in Non-Infectious Uveitis
    Walscheid, Karoline
    Weinhage, Toni
    Foell, Dirk
    Heinz, Carsten
    Kasper, Maren
    Heiligenhaus, Arnd
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (02) : 330 - 337
  • [40] Real-World outcomes of adalimumab in adults with non-infectious uveitis
    Leal, Ines
    Wong, Shiao Wei
    Giuffre, Chiara
    Patil, Ajay
    Sousa, David Cordeiro
    Barbosa-Breda, Joao
    Chhabra, Ramandeep
    Jones, Nicholas P.
    Steeples, Laura R.
    [J]. ACTA OPHTHALMOLOGICA, 2022, 100 (07) : E1496 - E1502